Krystal Biotech Inc
NASDAQ:KRYS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Krystal Biotech Inc
NASDAQ:KRYS
|
US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
O
|
Omnia Holdings Ltd
JSE:OMN
|
ZA |
|
Electronic Arts Inc
NASDAQ:EA
|
US |
|
Warner Bros Discovery Inc
NASDAQ:WBD
|
US |
|
UWM Holdings Corp
NYSE:UWMC
|
US |
|
Aviva PLC
LSE:AV
|
UK |
|
Shurgard Self Storage Ltd
XBRU:SHUR
|
GG |
|
P
|
Pepkor Holdings Ltd
JSE:PPH
|
ZA |
|
Dios Fastigheter AB
STO:DIOS
|
SE |
|
Becton Dickinson and Co
NYSE:BDX
|
US |
|
Azerion Group NV
AEX:AZRN
|
NL |
|
TC Energy Corp
TSX:TRP
|
CA |
|
F5 Inc
NASDAQ:FFIV
|
US |
|
G
|
Grandvision NV
F:8GV
|
NL |
|
Airtel Africa PLC
LSE:AAF
|
UK |
|
Premia Finance SpA Societa di Mediazione Creditizia
MIL:PFI
|
IT |
|
Secom Co Ltd
TSE:9735
|
JP |
|
Avalo Therapeutics Inc
NASDAQ:AVTX
|
US |
Wall St Price Targets
KRYS Price Targets Summary
Krystal Biotech Inc
According to Wall Street analysts, the average 1-year price target for KRYS is 320.99 USD with a low forecast of 217.15 USD and a high forecast of 399 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KRYS's stock price target?
Price Target
320.99
USD
According to Wall Street analysts, the average 1-year price target for KRYS is 320.99 USD with a low forecast of 217.15 USD and a high forecast of 399 USD.
What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
17%
The compound annual growth rate for Revenue over the next 8 years is 17%.
What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
26%
The compound annual growth rate for Operating Income over the next 8 years is 26%.
What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
16%
The compound annual growth rate for Net Income over the next 7 years is 16%.
